Nanocytomics LLC
Northbrook, IL
- UEI
- U4RAHVD6K3D8
- CAGE
- 6E4N0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 500 Skokie Blvd #275, Northbrook, IL 60062, USA
- Website
- nano-cytomics.com
- Founded
- 2011
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Northwestern University | R01CA225002 | -$38,041 | |
| Northwestern University | R01CA225002 | $82,500 | |
| Northwestern University | R01CA225002 | $20,249 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Exomira Medicine Inc. | Chicago, IL | — |
| Curii Corporation | Cambridge, MA | 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services |
| QT Imaging, Inc. | Novato, CA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Invenio Imaging Inc. | San Jose, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Celltrans Inc. | Chicago, IL | 621511 Medical Laboratories |
About the company
Nanocytomics LLC, a for-profit limited liability company based in Northbrook, Illinois, operates as a subrecipient on federal biomedical research grants focused on translational oncology and nanotechnology-enabled clinical diagnostics. The vendor holds no prime contracts but participates in the federal grant ecosystem as a sub-recipient on National Institutes of Health and National Science Foundation awards, with all recent visible sub-award activity flowing through Northwestern University as the prime recipient.
Nanocytomics' federal footprint concentrates heavily in cancer-screening innovation. The National Cancer Institute (part of NIH) accounts for seven of nine awards in the source data, representing 100% of the top-customer ranking by count. The vendor's core capability portfolio centers on translational nanocytology for lung cancer detection — specifically, the clinical translation of buccal nanocytology screening methods. Three consecutive sub-awards from Northwestern University document progression on the same research line: "Translating buccal nanocytology for lung cancer screening into clinical practice" (sub-awards dated April 30, 2024; November 13, 2024; and July 15, 2025). A single National Science Foundation award and one additional Department of Health and Human Services award round out the named customer set. Combined federal obligation across all nine awards totals $7.1 million, with awards dispersed across a thirteen-year window from 2012 to 2025. The vendor's award cadence is sparse and irregular — three awards in 2012, then a five-year gap, followed by isolated awards in 2015 and 2016, then a three-year gap before resumption in 2024 — reflecting the episodic nature of grant funding cycles and the vendor's positioning as a subordinate research partner on NIH-NCI translational oncology initiatives.
Quick answers
Is Nanocytomics LLC registered in SAM.gov?
Yes. Nanocytomics LLC's SAM.gov registration is active through February 4, 2027.
What is Nanocytomics LLC's most recent federal award?
Nanocytomics LLC's most recent federal grant award is Buccal nanocytological risk stratification to personalize lung cancer screening (R44CA206844), from National Cancer Institute (NIH), on September 1, 2016.
On GovTribe
See Nanocytomics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors